Robert W Fairbairn sold $308k of BMEZ
director at BlackRock Health Sciences Term Trust. 20,589 shares at an average of $14.98, traded Dec 18, 2025, filed Dec 22, 2025.
Score components
- +15RoleDirector
- +14Trade size$308k at market
- +20Share of holdings soldSold 100% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +3.3%, 3m -6.6%, 6m +0.7%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-25-329003, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 18, 2025 | SOpen-market sale Common Stock | -10,294 | $14.98 | $154k | 0 | Dec 22, 2025 |
| Dec 19, 2025 | SOpen-market sale Common Stock | -0 | $14.96 | $6 | 0 | Dec 22, 2025 |
| Dec 18, 2025 | SOpen-market sale Common Stockindirect: By spouse | -10,294 | $14.98 | $154k | 0 | Dec 22, 2025 |
| Dec 19, 2025 | SOpen-market sale Common Stockindirect: By spouse | -0 | $14.96 | $6 | 0 | Dec 22, 2025 |
Related signals
Other insiders at BlackRock Health Sciences Term Trust and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 32Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $1.0M 64,716 shares | +0% | |
| 15Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $243k 15,281 shares | +0% | |
| 27Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $2.1M 129,372 shares | +1% | |
| 14Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $224k 13,781 shares | +0% | |
| 27Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $2.6M 159,008 shares | +1% | |
| 27Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $1.6M 97,748 shares | +0% | |
| 32Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $3.7M 225,876 shares | +1% | |
| 32Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $4.4M 271,620 shares | +1% | |
| 32Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $4.3M 267,863 shares | +1% | |
| 27Weak | BMEZbuy BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $2.6M 162,282 shares | +1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.